Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-05-27

Clinical Trial Update: EScitalopram PIndolol ONset of Action [Phase 2, Phase 3]

View source ↗

Summary

The document notes termination of a Phase 2/3 trial evaluating escitalopram combined with pindolol for major depressive disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Escitalopram (escitalopram)
  • PINDOLOL (PINDOLOL)

Snippet

Sponsor: Markus KOSEL | Conditions: Unipolar Depression | Phase 2, Phase 3 | Status: TERMINATED